Jazz Pharmaceuticals (JAZZ) Debt Ratio (2010 - 2026)

Jazz Pharmaceuticals' Debt Ratio history runs 17 years deep, the most recent figure standing at 0.45 for Q1 2026.

• In Q1 2026, Debt Ratio fell 3.53% year-over-year to 0.45; the TTM figure through Mar 2026 stood at 0.45 (down 3.53% YoY), while the FY2025 annual figure was 0.55, up 7.74% from the prior year.
• Debt Ratio for Q1 2026 stood at 0.45, down from 0.55 in the prior quarter.
• The five-year high for Debt Ratio was 0.58 in Q2 2025, with the low at 0.45 in Q1 2026.
• The 5-year median for Debt Ratio is 0.51 (2022), against an average of 0.52.
• The sharpest annual moves came in 2022 and 2023: Debt Ratio surged 64.55% in 2022, then dropped 8.0% in 2023.
• Jazz Pharmaceuticals' Debt Ratio stood at 0.53 in 2022, then decreased by 5.09% to 0.5 in 2023, then grew by 1.42% to 0.51 in 2024, then advanced by 7.74% to 0.55 in 2025, then declined by 17.59% to 0.45 in 2026.
• Business Quant data shows JAZZ's Debt Ratio at 0.45 in Q1 2026, 0.55 in Q4 2025, and 0.56 in Q3 2025.